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Abstract  
Acute mountain sickness (AMS) is a neurological disorder that typically affects 
mountaineers who ascend to high-altitude. The symptoms have traditionally been 
ascribed to intracranial hypertension caused by extracellular vasogenic edematous brain 
swelling subsequent to mechanical disruption of the blood-brain barrier (BBB) in 
hypoxia. However, recent diffusion-weighted magnetic resonance imaging (MRI) studies 
have identified mild astrocytic swelling caused by a net redistribution of fluid from the 
“hypoxia-primed” extracellular space to the intracellular space without any evidence for 
further barrier disruption or additional increment in brain edema, swelling or pressure. 
These findings and the observation of minor vasogenic edema present in individuals with 
and without AMS suggest that symptoms are not explained by cerebral edema.   This has 
led to a re-evaluation of the relevant pathogenic events with a specific focus on free 
radicals and their interaction with the trigeminovascular system (TVS).  
 
Key words: acute mountain sickness; blood-brain barrier; cerebral edema; brain 
swelling; intracranial hypertension; free radicals; inflammation; trigeminovascular system 
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Perspective 
Acute mountain sickness (AMS) and high-altitude cerebral edema (HACE) are caused by 
hypoxia that typically affect mountaineers who ascend rapidly to high-altitude [1]. While 
it is well-established that patients with HACE exhibit extracellular (vasogenic) edema 
subsequent to disruption of the blood-brain barrier (BBB)[2], the situation with AMS is 
more complex, due in part to difficulties associated with clinical diagnosis. While 
controversial [3], current opinion suggests that AMS is a mild form of HACE and that 
both syndromes share a common pathophysiology linked by vasogenic edematous brain 
swelling and intracranial hypertension [1,4].  
 
However, the advent of sophisticated neuro-imaging technologies has provided unique 
insight into the molecular and vascular mechanisms associated with these high-altitude 
illnesses. Since the literature has dealt so comprehensively with the clinical, 
epidemiological and therapeutic bases of AMS and HACE [1,3,5], the purpose of the 
current paper is to critically review the emerging and often-times contentious issues 
surrounding pathophysiology with a focus on the molecular bases of disease.  
 
First, we consider the atomic structure of the diatomic O2 molecule to reveal a more 
nebulous side to a “free radical” gas traditionally considered the elixir of life which the 
brain has evolved to be so heavily dependent upon yet can prove paradoxically fatal when 
in excess. We discuss how redox-sensitive mechanisms are activated by hypoxia with 
free radicals assuming a protective rather than a purely destructive role that serve to 
defend cerebral O2 homeostasis and the neurovascular complications that arise when the 
brain’s “O2-sensing” apparatus fails to respond adequately. Finally, in the light of recent 
neuro-imaging findings, we critically examine whether AMS is indeed a mild form of 
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HACE and whether symptoms can be ascribed to intracranial hypertension subsequent to 
vasogenic edematous brain swelling.  
 
Oxygen and the brain 
Photosynthesizing cyanobacteria breathed life into what was until a billion years ago 
considered a reductive atmosphere, thus providing a selective pressure for the evolution 
of O2-dependent micro-organisms that began with the autotrophic eukaryotes [6]. Since 
these primordial times, the respiring mammalian cell has become entirely dependent on 
molecular O2 since it serves as the terminal electron acceptor in mitochondrial oxidative 
phosphorylation and multiple enzymes require O2 as a substrate [7].   
 
The human brain exemplifies this reliance on O2 since unlike most other tissues it is 
committed to a continually active state. Weighing less than 2% body mass it accounts for 
an impressive, albeit disproportionate 25% of the basal O2 budget. This ability to process 
large amounts of O2 over a relatively small tissue mass is required to support the high rate 
of adenosine tri-phosphate (ATP) production to maintain an electrically active state for 
the continual transmission of neuronal signals [8].  
 
However, this obligatory high rate of cerebral O2 consumption is associated with a 
correspondingly high vulnerability for failure. In the human brain, ATP concentrations 
fall drastically within minutes of anoxia which can result in devastating consequences as 
the complications associated with stroke and head trauma clearly stand testament to. 
However, evolution solved this problem millions of years ago with the emergence of 
anoxia-tolerant vertebrates such as the freshwater turtle and the carp fish which display 
extraordinary abilities to cope with functional disturbances in cerebral O2 delivery [9]. 
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Though the human brain’s defense mechanisms against hypoxia are impressive, they pale 
into insignificance when compared with those exhibited by the ectothermic vertebrates 
[8]. 
  
Bi-radical O2; a thermodynamic quirk of evolution 
Before we consider the more subtle aspects of hypoxia and its impact on central nervous 
system (CNS) function at high-altitude, it is worth emphasizing that the brain relies on 
what is essentially a mutagenic gas. Our pre-occupation with improving O2 delivery to 
respiring tissue often begets the vascular complications caused by “O2 excess” which is 
toxic to the CNS and can often prove fatal. 
 
This is because the triplet ground state diatomic O2 molecule exists as a free radical with 
two unpaired electrons each located in a different pi* molecular orbital but with the same 
spin quantum number (Figure 1). Fortunately, unlike most other oxidizing free radical 
species, this parallel spin renders O2 less reactive at “normal” concentrations despite its 
powerful oxidizing nature. This “spin-restriction” is a thermodynamic quirk of evolution 
and the fact that O2 prefers to accept one electron at a time protects the organic bio-
molecules of the human brain from spontaneous combustion!  
→ Please insert Figure 1 here 
However, at elevated partial pressures of O2 (PO2), the mitochondrial formation of the 
univalent reductant, the superoxide anion (O2-•) increases and is considered the major 
source of the biological damage associated with O2 toxicity [10]. Though not especially 
reactive (EO΄ = +940mV), O2-• can be converted to hydrogen peroxide (H2O2) through 
reduction or dismutation and upon reaction with transition metal ions, can form the 
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hydroxyl species (OH•). This species is at the top of the free radical “pecking order” (EO΄ 
= +2310mV) and thermodynamically capable of oxidizing any bio-molecule that it 
collides with at a rate constant very near the diffusion limit [11].   
 
Contemporary physiology emphasizes the conceptual significance of the “O2-cascade” 
which describes an ever-decreasing PO2 gradient to provide a “pressure-head” to 
maintain diffusive O2 flux from the ambient to the (cerebral) mitochondrion [12]. What is 
often overlooked however is the concept that the endogenous resistances offered to O2 
transport may have evolved, by chance or by fate, to protect the cell from the full force of 
O2, an in-built antioxidant defence system. The fact that the Michaelis constant (Km) of 
the terminal reductant, cytochrome c oxidase for O2 is so extraordinarily low (0.03-
0.3mmHg) [13] stands testament to how important it is to harness this molecule and 
maintain cellular PO2 within “safe” biological limits.   
 
Molecular targets of oxidative stress  
Our reliance on this toxic gas is matched by an equally paradoxical finding; despite its 
limited regenerative capacity, the brain is poorly equipped to cope with these potentially 
damaging free radical reactions [14]. Nervous tissue seems to out-perform other tissues in 
that it is more prone to O2-• formation with advancing age [15].  
 
Several features related to the molecular composition of the brain and biochemical milieu 
it supports render it particularly vulnerable to free radical attack. For example, 
antioxidant defenses are modest at best and neuronal membrane lipids rich in 
eicosapentaenoic (C20:5) and docosahexaenoic (C22:6) polyunsaturated fatty-acid side 
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chains are especially susceptible to lipid peroxidation.  Second to adipose tissue, nerve 
tissue contains the highest concentration of these highly peroxidizable lipids. A dense 
network of mitochondria exposed to a high mass-specific O2 flux, autoxidizable 
neurotransmitters, cytochrome P450 and reactive microglia also serve to compound O2-• 
formation. Excito-toxic amino acids and highly active neuronal Ca2+ trafficking further 
contribute to the brain’s oxidant burden [16].  
 
However, what makes the brain especially vulnerable to oxidation is the fact that it is rich 
in iron, particularly the globus pallidus (up to 370µg/g tissue wet weight), basal ganglia, 
substantia nigra, red nucleus, caudate nucleus and putamen [17] that if not adequately 
regulated, can promote damage [14].  Unlike human plasma, cerebrospinal fluid (CSF) 
has no significant iron-binding capacity since transferrin content is remarkably low and 
thus considered at or close to saturation [18].  Thus, the high rate of O2-• formation 
coupled with mounting potential for cerebrovascular tissue damage could potentially 
unlock Fe2+ to catalyze Fenton/Haber-Weiss driven generation of OH• to initiate neuronal 
apoptosis to further compound membrane destabilization and vascular damage. 
Ironically, ascorbate, the most effective aqueous-phase chain-breaking antioxidant is 
present in high concentrations in the white and the grey matter and has the capacity to 
further aggravate oxidative catalysis [14]. 
 
The concept that the human brain is “oxidatively-primed” with a poor ability to contain 
these potentially damaging free radical chain reactions [16] has important implications 
for the morphological changes that occur in response to hypoxia which is the focus of 
subsequent discussion. The reader is encouraged to consult several excellent reference 
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texts that deal comprehensively with the source, mechanisms and functional 
consequences of biologically-relevant free radical species [11,19]. 
 
The adaptive response to hypoxia; O2 “sensing” 
This reliance on O2 renders the human brain exquisitely sensitive to hypoxia and as a 
consequence, elaborate cellular oxygen-sensing mechanisms have evolved to defend 
cerebral O2 homeostasis to ultimately prevent brain damage in the face of a blunted PO2. 
The search for a “unifying” O2 sensor has stimulated enormous research interest with 
numerous candidate proteins proposed which have been discussed in detail by Drs Pugh 
and Simone in this issue.  
 
One elegant theory that is gaining prominence is the notion that the mitochondra function 
as the primary “O2 sensors” [20]. This makes intuitive sense since they bind O2 at the 
cytochrome oxidase and represent the primary site of cellular O2 consumption. However, 
the “cornerstone” of the mitochondrial model, the concept that hypoxia accelerates free 
radical formation represents “yet another O2 paradox” [21] and remains the subject of on-
going controversy. Though elegant by design, this model has been met with some 
resistance mostly because cytochrome oxidase activity does not become O2 limited until 
concentrations fall to pathophysiologically low levels in the order of ≈1mmHg or <1% 
[22]. 
 
The mitochondrial model contends that hypoxia triggers free radical release mostly from 
Complex III and that these act as signaling molecules that ultimately activate O2 
“salvage” genes through stabilization of the transcription factor hypoxia-inducible factor 
(HIF)-1α [22]. Hypoxia is known to increase the expression of both astrocytic and 
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neuronal erythropoietin (EPO) [23] and vascular endothelial growth factor (VEGF) 
mRNA [24] which serve to not only increase O2 transport but also reduce neuronal 
apoptosis and counteract inflammation. Thus, the brain walks a biochemical tight-rope; it 
needs to carefully titrate free radical formation to optimize O2 delivery while limiting the 
potential for vascular damage. It would appear that the brain pivots delicately between a 
bimodal distribution of free radicals that can cause damage when in excess under both 
hypoxic and hyperoxic PO2’s (Figure 2). Understanding what constitutes a 
physiologically “appropriate” concentration of free radicals in the hypoxic human brain 
and how this is achieved remains the Holy Grail for molecular biologists and 
physiologists alike.  
→ Please insert Figure 2 here 
When the molecular and physiological adaptations unite, global cerebral energetics 
remain remarkably well-preserved at least during moderate hypoxia when arterial 
hemoglobin O2 saturations (SaO2) fall to 80% even in the face of hypocapnia (PaCO2 ≈ 
25mmHg) [25]. The cerebral metabolic rate for oxygenation and glucose are also 
maintained at normal levels for up to 21 days of hypoxia [25]. However, while existing 
measurement techniques fail to identify any evidence for a global O2 deficit in the human 
brain, positron-emission tomography (PET) measurements of [18F]2-deoxy-2-fluoro-D-
glucose uptake have revealed striking spatio-temporal differences in the brain’s energy 
consumption [26]. The hippocampus and specifically the CA1 neurons, the corpus 
striatum and Purkinje cells of the cerebellum are especially sensitive to the severe 
hypoxia associated with ischemia [27]. Furthermore, neurotransmitters, the ubiquitous 
regulators of neuronal activity, are particularly vulnerable in light of their 
correspondingly high Km for O2 [28]. 
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This high-rate of metabolic activity in the human brain contrasts with that observed in 
hypoxic-tolerant ectothermic species and diving mammals, particularly the aquatic turtle 
who exhibit a remarkable ability to suppress cerebral metabolism and thus optimize 
energy demand-supply coupling as part of a coordinated defense strategy [29]. 
Preliminary indications suggest that a similar strategy exists in humans born and bred at 
high-altitude (native highlanders) particularly in regions classically associated with 
higher cortical functions (frontal cortex and angular gyri) thus indicating that cerebral 
hypometabolism likely represents a universal adaptation of the CNS in hypoxia-tolerant 
species [30].  
 
Thus, at least in the native lowlander, it is conceivable that focal metabolism and 
neuronal communication may become impaired even with subtle reductions in the 
inspired PO2. This certainly appears to be the case in those individuals who, for reasons 
that remain unclear, appear more “hypoxia-sensitive” and as a consequence, less able to 
defend systemic and cerebral oxygenation. This phenotype is the focus of subsequent 
discussion since these individuals appear to be more susceptible to the high-altitude 
syndromes that affect the brain, specifically AMS and HACE.   
 
AMS and HACE 
AMS is a syndrome of non-specific symptoms typically experienced by non-acclimatized 
mountaineers within 6-12h of arrival to altitudes above 2500m [1,3]. It is defined by the 
presence of headache plus at least one of the following symptoms; anorexia, nausea, 
vomiting, fatigue, dizziness and insomnia. AMS is generally benign though may progress 
to HACE in more severe cases or during continued ascent above 4000m when symptoms 
of AMS are present. HACE is characterized by altered consciousness, ataxia or both in a 
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subject with AMS or high-altitude pulmonary edema (HAPE) and if left untreated, can 
result in death subsequent to brain herniation [1].  
 
Pathophysiology; the traditional paradigm 
Current opinion suggests that AMS is a self-limiting mild form of HACE and that both 
syndromes share a common pathophysiology linked by vasogenic edematous brain 
swelling that ultimately leads to intracranial hypertension [1]. Intracranial hypertension 
has been believed to be the primary cause of AMS since the displacement and stretching 
of pain-sensitive unmyelinated fibres that reside within the trigeminovascular system 
(TVS) provides an elegant mechanism for the headache [31]. The events that conspire to 
increase intracranial volume (ICV) have since become the focus of detailed investigation 
since this is considered the key to understanding the underlying pathophysiology [4].  
 
However, recently published diffusion-weighted magnetic resonance imaging (MRI) 
studies [32-35] have challenged the traditional paradigm which has led to a revised 
hypothesis and subsequent modification of the molecular, metabolic, hemodynamic and 
morphological events traditionally considered important in AMS and HACE.  
 
Morphological response to hypoxia; the normal (adaptive) phenotype 
Figure 3 summarizes the “typical” sequence of events that occur in the human brain in 
response to hypoxia which is considered the “upstream” stimulus responsible for 
activation of the adaptive molecular apparatus that serves to maintain cerebral O2 
homeostasis. However, there are rebound consequences “downstream” that increase the 
potential for cerebral hyper-perfusion (mechanical forces) and capillary leak (chemical 
forces) which can encourage the formation of extracellular cerebral edema. Cerebral 
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blood flow (CBF) measured using the Kety-Schmidt [36], Xenon-133 [37] or Doppler 
sonography of the middle cerebral artery [38] techniques has been shown to increase and 
disordered cerebral autoregulation has also been documented in response to high-altitude 
hypoxia [39]. Furthermore, the circulating concentration of free radicals [32,40,41] and 
free vascular endothelial growth factor (VEGF) also increase in hypoxia [42] thus 
providing a chemical stress with the potential to increase BBB permeability. These 
responses eventually conspire to increase cerebral capillary hydrostatic pressure and 
promote albeit mild extracellular (vasogenic) edema and brain swelling subsequent to 
hydrostatic disruption of the BBB independent of AMS.  
→ Please insert Figure 3 here 
Two recently published MRI studies (1.5-3T) provided convincing evidence for mild 
vasogenic edematous brain swelling following 6-18 hours passive exposure to 
normobaric hypoxia in a simulated high-altitude chamber (FIO2 ~12%) [33,34]. 
Vasogenic edema was detected both in subjects diagnozed with clinical AMS (AMS+) 
and in healthy subjects who were free of symptoms (AMS-) [33,34]. In contrast, 
intracellular edema was confined solely to AMS+, in particular those with more severe 
symptoms [33,34].  
 
One of these two studies [34] identified extracellular edema defined by a significant 
increase of both apparent diffusion coefficients (ADC derived from diffusion-weighted 
images) and B0 values [T2 relaxation times (T2rt) derived from T2-weighted images] in 
the white matter. In the other study [33], extracellular edema was confined to the 
splenium of the corpus callosum, the same predilection site in patients with HACE [2]. 
The predilection for the corpus callosum may be a consequence of its rather unique 
vascular anatomy; densely-packed horizontal fibers characterized by short arterioles that 
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lack adrenergic tone may render it more susceptible to hyper-perfusion edema in the 
setting of hypoxic cerebral vasodilatation [2]. However, it is important to note that the 
MRI examinations of AMS+ and AMS- subjects was performed during exposure to 
hypoxia, whereas MRI of patients with HACE was performed up to 6 days following 
evacuation to lower altitudes (ie. in normoxia). Thus, the possibility that both vasogenic 
and cytotoxic edema “co-exist” in HACE remains to be examined [2,43]. 
 
In one study which focused on the molecular determinants of altered morphology, there 
was no evidence of “gross” barrier dysfunction or neuroglial damage as indicated by the 
lack of change in the serum and CSF concentration of S100β, neuron-specific enolase 
(NSE) and CSF-blood protein concentration quotients [32]. Furthermore, there has been a 
general failure to detect any visual signs consistent with cerebral edema such as midline 
shift, mass effect, effacement of sulci, ventricle collapse or compression of cisterns 
(Figure 4) and lumbar pressure also appears to be normal [32]. The astrocytic protein 
S100β was incorporated as a specific marker of BBB integrity since recent studies 
incorporating osmotic opening of the BBB have identified that extravasation of this 
astrocytic protein in blood can occur in the absence of or preceding neuroglial damage 
[44-46]. Thus, the MR evidence to date indicates a minor as opposed to a major breach of 
barrier function which is so subtle that it is indeed beyond standard molecular detection 
limits.  
→ Please insert Figure 4 here 
Priming of the extracellular space (ECS) may actually prove of functional significance 
and represent an adaptive response to hypoxia. An increase in the ECS would serve to 
buffer any rise in the interstitial concentration of neurotransmitters such as glutamate and 
glycine thus reducing the risk of a tonic activation of NMDA receptors [47]. Furthermore, 
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it may also attenuate extracellular K+ that could threaten to depolarize the brain [48]. 
Interestingly, neonates who are far more hypoxia-resistant than adults, exhibit an 
enlarged ECS (15-25% of the whole brain compared to 10-20% in the adult) [49]. 
Though speculative, vasogenic edematous brain swelling may prove an adaptive response 
in the hypoxia-tolerant human. 
 
AMS; the maladaptive phenotype? 
One would anticipate that these changes would be more pronounced in AMS+ subjects 
consistent with the vasogenic hypothesis. However, no relationship was identified 
between the hypoxia-induced increase in brain volume, T2rt or ADC and cerebral AMS 
scores [33,34]. Furthermore, post-hoc analysis indicated that there were no differences in 
volumetrics or relaxometry when AMS+ were compared against AMS- subjects. The 
morphological findings were further complemented by the lack of any molecular-
biochemical evidence for altered BBB function or neuronal-parenchymal damage. These 
important studies emphasize three conceptually important findings; [1] mild vasogenic 
edematous brain swelling represents the typical, arguably adaptive phenotypical response 
to hypoxia that has little bearing on the symptoms of AMS, [2] edema occurs in the 
absence of a “major” breach of the BBB and [3] the “AMS brain” is not characterized by 
any additional volume overload thus excluding intracranial hypertension as a significant 
pathophysiological event.  
→ Please insert Figure 5 here 
Anatomy; intracranial-intraspinal buffering capacity 
Borne out of an original hypothesis developed over 20 years ago [50], the lack of 
correlation between brain swelling and AMS symptoms has since been ascribed to 
anatomical differences that determine how effectively the human skull can accommodate 
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swelling through displacement of cranial CSF to extra-cranial compartments [1]. Thus, 
individuals characterized by a smaller ratio of cranial CSF to brain volume (popularized 
as the “tight-fit” brain) would be expected to be more prone to intracranial hypertension 
and thus by consequence AMS, since they are less capable of “buffering” the volume 
increase through changes in CSF dynamics due to an inadequate cranio-spinal axis CSF 
reserve.  
 
To date, only one human study has provided indirect evidence to support the “tight-fit” 
hypothesis with AMS+ subjects retrospectively identified as having comparatively larger 
brain volume to intracranial volume ratios even at sea-level [33]. Though elegant by 
design, we are not entirely convinced that this has any bearing on the pathophysiology of 
AMS and likely represents an incidental finding. It would seem highly unlikely that the 
volumetric changes imposed would translate into any physiologically meaningful changes 
in the mechanical displacement of pain-sensitive structures that could activate the TVS 
[3]. The small increases in ICV documented in the literature likely occupy the flat-part of 
the ICP-volume curve and eminently well-buffered by semi-elastic membranes and 
changes in CSF dynamics [28]. 
 
Reduced ADC score associated with increased T2rt in AMS; interpretation and 
significance 
Arguably one of the most important findings in recent years relates to the combined 
observation that AMS+ subjects exhibited a selective decrease in ADC scores in hypoxia 
and that this was not associated with any additional evidence of vasogenic edematous 
brain swelling beyond the mild changes incurred by hypoxia per se [33,34]. This finding 
was unexpected in light of the prevailing vasogenic hypothesis. Both groups interpreted 
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this as evidence for an additional, albeit mild intracellular (cytotoxic) edema 
superimposed on a pre-existing extracellular vasogenic edema provoked by hypoxia.  
 
The lack of any difference in the 3T-MRS signal of lactate in AMS+ compared to AMS- 
(unpublished findings) confirms that the reduction in ADC was indeed a genuine finding 
that was not confounded by intra-cerebral lactacidosis which has been raised as a 
potential concern since the lactate anion can interfere with the ADC measurements [33]. 
Since both studies failed to identify any evidence for additional edema or brain swelling, 
the decrease in ADC likely reflects “fluid re-distribution” from within the ECS as 
intracellular (astrocytic) swelling proceeds without any additional increment in brain 
volume, edema or ICP [51].  
 
However, the critical question that remains unanswered is whether AMS is caused by 
such a “minor” shift of water into the cells of the corpus callosum that entered as a result 
of mild vasogenic edema in hypoxia. Edema of the corpus callosum would be expected to 
cause a disconnection syndrome but no symptom of AMS.  
 
The observation that intracellular swelling occurs in hypoxia is not new with early studies 
documenting up to a 0.25L (+12%) increase in the intracellular fluid compartment, albeit 
in skeletal as opposed to cerebral tissue [52]. This has been attributed to a down-
regulation of (muscle) cell membrane ionic pumping subsequent to inactivation of the 
Na+/K+-ATPase [53]. The hypoxic suppression of BBB ion-pumping activity may 
therefore provide an alternative explanation for the accumulation of extracellular fluid 
recently observed in the brain independent of barrier disruption [32]. Other mechanisms 
such as increased Na+ and K+ permeability of the cell membrane and a sustained uptake 
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of osmotically-active solutes may have also contributed to what has been coined “pump-
leak-equilibrium disturbance” [54].  
 
Intracranial pressure 
While the technical challenges posed by the accurate, non-invasive assessment of ICP are 
acknowledged, the human evidence in support of elevated ICP in AMS remains limited 
despite preliminary indications of decreased compliance (for a review see [28]). This 
contrasts with the findings reported by Krasney et al. [55] in the hypoxic sheep model 
which lends itself to a more invasive approach. However, it is important to recognize the 
limitations associated with this model, most notably the unavoidable difficulties 
associated with the clinical definition of AMS.  
 
More recently, B-scan ultrasound of the eye was employed to assess the optic sheath 
nerve diameter (OSND) to provide non-invasive insight into ICP changes during an 
active ascent of Mt. Everest [56]. The authors demonstrated an association between 
OSND and AMS symptom scores thus arguing a pathogenic role for intracranial 
hypertension. However, closer inspection of their data reveals a physiologically 
insignificant increase in OSND (+0.02mm) at the intermediate altitudes of 2000-3700 
where symptoms of AMS typically present. Furthermore and by the authors’ own 
admission, at the higher altitude of 6400m, OSND actually increased as symptoms tended 
to resolve. In summary, there is no clear human evidence to suggest that ICP is raised in 
AMS [3]. 
 
This makes intuitive sense when one considers that intracranial hypertension would only 
be expected to occur when the ECS has been compressed to its maximum degree with the 
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volume of the swollen astrocytes exceeding the volume translocated from the ECS [51]. 
In the two most recent neuro-imaging studies, the water entering the astrocytes likely 
originated from the plasma in the ECS which had already expanded during the phase of 
mild vasogenic edema observed in hypoxia (illustrated in Figure 2). However, the volume 
available for “re-distribution” was very small indeed in light of the modest changes 
observed in brain volume (+0.6 ± 0.4%) [33] and lack of BBB disruption [32]. Recent 
estimates suggest that astrocytes need to swell by up to as much as 60% before cytotoxic 
edema and thus brain swelling can occur [51].  
 
An emerging hypothesis; astrocytic swelling and redox-regulation of TVS activation 
These findings clearly fail to support the traditional theory that AMS is caused by 
intracranial hypertension as a result of vasogenic edematous brain swelling [1] and have 
led to the formulation of an alternative hypothesis with a specific focus on the TVS. The 
reader is referred to an excellent review for a more thorough discussion of the anatomy 
and subsequent modulation of trigeminovascular nociceptive input from the meningeal 
vessels albeit during the pathophysiology of migraine pain [57].    
 
Figure 6 presents the revised sequence of events that warrant future investigation and 
compares and contrasts these with those currently supported by the literature. The schema 
describes how inspiratory hypoxia catalyzes mitochondrial O2•- and subsequent OH• 
formation through Fenton and Haber-Weiss chemistry. These “upstream” radicals are 
eminently capable of causing neurovascular endothelial dysfunction, depressing hypoxic 
ventilatory control and pulmonary gas exchange [58] and thus provide a molecular basis 
to explain why AMS+ subjects are typically more hypoxemic for any given FIO2 [16]. 
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Free radicals may be responsible for “pump failure” since they can reduce Na+/K+-
ATPase activity which may prove the mechanism responsible for ECF re-distribution and 
subsequent expansion of the astrocytic space independent of any global volumetric 
changes to the brain [33,34]. It is tempting to speculate that AMS may represent an 
“ionopathy” characterized by free radical-mediated ion channel dysfunction whose 
activity and distribution in the hypoxic brain determine the clinical phenotype. Astrocyte 
swelling can directly activate p47phox-dependent NADPH oxidase [59] and further 
compound “osmotic-oxidative stress”. Astrocyte swelling has also been shown to 
increase cerebral nitric oxide formation [60] that, in combination with the increase in free 
radical-mediated lipid peroxidation and subsequent membrane destabilization further 
compounded by local HIF-1α and VEGF activation and inflammation, can directly 
activate the TVS, the final common pathway.  
 
Though controversial, direct inhibition of TVS activity with sumatriptan, a selective 5-
hydroxytryptamine1B/1D agonist and cerebral vasoconstrictor has recently been shown to 
provide effective prophylaxis and reduced the relative risk of AMS by over 50% [61]. In 
addition to its ability to attenuate cell excitability in trigeminal nuclei via stimulation of 
5-HT1B/1D receptors within the brainstem and vasoconstriction of meningeal, dural, 
cerebral or pial vessels via stimulation of vascular 5-HT1B/1D receptors, sumatriptan can 
directly scavenge O2•- NO and OH• [61]. We have recently provided direct electron 
paramagnetic resonance (EPR) spectroscopic evidence for increased OH• and 
downstream formation of lipid-derived free radical species in the CSF of a subject 
diagnozed with severe AMS (Figure 7). Furthermore, the neuroprotective benefits 
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conferred by dietary antioxidant vitamin prophylaxis add further support to the redox-
TVS-activation hypothesis [62].  
 
The link to HACE 
While HACE has traditionally been ascribed to vasogenic edema [1], it is reasonable to 
assume that cytotoxic edema may also be present [2,43] since hypoxaemia is likely more 
marked compared to AMS. Therefore, cell swelling should even be even more enhanced 
in HACE. However, support for this hypothesis by measurements of ADC immediately 
after evacuation from altitude in patients with HACE is lacking and thus at present 
remains speculative. Thus, it is conceivable that both AMS and HACE share similar 
features in that there is an underlying vasogenic component (albeit mild and not 
responsible for symptoms in AMS) that subsequent to a  more pronounced regional O2 
diffusion limitation, may trigger intracellular swelling that is yet to be confirmed in 
HACE. In this sense, AMS may be considered a mild form of HACE.  
 
In addition, HACE may also reflect the more extreme spectrum of osmotic-oxidative 
stress resulting in gross BBB dysfunction, cerebral capillary “stress failure” and 
erythrocyte extravasation. This was confirmed in a recent study that combined 
conventional T2* with a novel, highly-sensitive susceptibility-weighted MRI technique to 
reveal multiple “microbleeds” detected as hemosiderin deposits confined to the genu and 
splenium of the corpus callosum (Figure 8) of HACE patients [63]. The failure to detect 
any hemosiderin deposits in subjects diagnozed with severe AMS supports the concept 
that vasogenic edema is minor in AMS and does not account for symptoms and points to 
a novel diagnostic feature  that may  discriminate between AMS and HACE. 
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Figure 1. Molecular orbital diagram of the electronic ground state (most stable form) 
diatomic oxygen molecule (3∑g-O2).  
 
Each line represents a molecular orbital and the arrows represent electrons, the direction 
of which indicates their spin quantum number. Note that O2 qualifies as a bi-radical since 
it contains two unpaired electrons each occupying different pi*2p anti-bonding orbitals 
(each missing electron is marked X). These unpaired electrons have the same spin 
quantum number (parallel spin). During the process of oxidation, O2 thermodynamically 
prefers to accept only one electron at a time into each of the vacant pi*2p anti-bonding 
orbitals to conform with the Pauli Exclusion Principle. Fortuitously, this “spin restriction” 
means that O2 does not react vigorously with the brain’s organic compounds and instead 
prefers to react with other radicals.   
 
              σ*2p 
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Figure 2. The healthy human brain pivots delicately between a bi-modal distribution of 
free radicals poised to increase in both hypoxia (that serve to defend cerebral 
oxygenation) and hyperoxia (capable of causing structural damage) subsequent to 
mitochondrial superoxide (O2•-) formation. The rate of increase in O2•- increases in 
hypoxia (primarily the Q cycle) and hyperoxia due to an increase in the concentration of 
electron donors (R•) and O2 concentration respectively. The resting intracellular partial 
pressure of oxygen is based on measurements recently documented in resting normoxic 
human skeletal muscle [64].    
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Figure 3. Normal response of the cerebral circulation to hypoxia. 
T2rt, T2 relaxation time; ADC, apparent diffusion co-efficient 
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Figure 4. 3T-T2 and diffusion-weighted (DW) images of a subject with clinical AMS. 
Note the lack of any visual difference between normoxia and following 6 passive 
exposure to hypoxia (12%O2) indicating that the edema detected by MRI is very subtle 
indeed. Baumgartner et al. (unpublished findings) based on [34].  
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Figure 5. Recent evidence suggesting that subjects diagnozed with clinical acute mountain sickness (AMS+) do not exhibit any additional 
increment in brain swelling (A), (vasogenic) edema (B), alteration in blood-brain barrier (BBB) permeability (C) or lumbar pressure (D). Data 
modified from [32] and values represent mean ± SD calculated as the difference between hypoxia relative to the normoxic control. 
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Figure 6. Revised schema of events implicated in the pathophysiology of acute mountain 
sickness (AMS) and high-altitude cerebral edema (HACE). The traditional model 
(stippled lines) contends that vasogenic edematous brain swelling combined with a 
reduced CSF buffering capacity may predispose to intracranial hypertension and thus by 
consequence, AMS (A). The revised model suggests that AMS is not associated with any 
“additional” volume overload thus arguing against a role for intracranial hypertension. It 
describes how free radicals can directly activate the trigeminovascular system to trigger 
neurovascular headache and AMS (B). HACE may reflect the more extreme spectrum of 
“osmotic-oxidative stress” resulting in gross barrier dysfunction and cerebral capillary 
“stress failure”. ICV, intracranial volume; ECS/ICS, extra/intra-cellular space. 
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Figure 7. X-band electron paramagnetic (EPR) spectroscopic detection of hydroxyl 
(OH•-A) and lipid-derived carbon-centered alkyl (LC•-B) free radicals in the 
cerebrospinal fluid of one subject in normoxia without acute mountain sickness (AMS-) 
and following 18h exposure to hypoxia (12%O2) when severe acute mountain sickness 
(AMS+) was diagnozed. EPR spectroscopy is considered the most sensitive, specific and 
direct molecular technique for the detection and subsequent identification of free radicals 
sine qua non [16]. The spectra illustrated were obtained using an ex-vivo spin-trapping 
technique [32]. The spin-traps 5,5-dimethylpyrroline-N-oxide (DMPO-1mм) and α-(4-
pyridyl 1-oxide)-N-tert-butylnitrone (POBN-50mм) were employed to detect proximal 
•OH and distal lipid-derived species respectively. Note the marked increase in free 
radical-mediated lipid peroxidation in AMS+. 
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Figure 8. Susceptibility-weighted T2*-images (A) obtained in one subject 7 weeks after 
CT diagnosis of HACE following ascent to 3860m and shortly following clinical 
diagnosis of severe AMS in a separate subject at 5895m. Note the multiple patchy hypo-
intensities (arrows) present in the HACE subject only that correspond to micro-
hemorrhages that result in hemosiderin (insoluble Fe(III) oxide hydroxide) deposition 
secondary to blood-brain barrier disruption and cerebral capillary “stress failure”. These 
“micro-bleeds” were located predominantly in the genu and splenium of the corpus 
callosum (B) which have previously been identified as predilection sites for vasogenic 
edema in HACE [2]. Data modified from [63].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
